COMP <GO>
KOD vs UNH // OPERATING MARGIN
Kodiak Sciences Inc (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: KOD 4
— UNH 10
▲ OPERATING MARGIN LEADER: UNH
LAST: $99.18 (-1.22%) • MKT CAP: $6.31B
operating-margins
-13.30%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
operating-margins
4.82%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KOD VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KOD | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 88.57% | -47.57 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 11.47% | -46.47 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.16% | 6.48% | -8.64 | UNH | /fcf-yield <GO> |
| Operating Margin ACTIVE | -13.30% | 4.82% | -18.12 | UNH | /operating-margins <GO> |
| Net Profit Margin | -13.00% | 3.14% | -16.14 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 1.10% | 6.46% | -5.36 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 16.70 | 3.12 | +13.58 | KOD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.74% | -0.14 | KOD | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.5 | 56.0 | +10.40 | KOD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.33 | +0.57 | KOD | /macro-sensitivity <GO> |
| Forward P/E Multiple | 35.0x | 17.1x | +17.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.31B | $364.66B | -$358.35B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KOD REV | UNH REV | KOD GROSS % | UNH GROSS % | KOD FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $447.57B | — | 88.7% | -$136.5M | $16.07B |
| FY 2024 | $0 | $400.28B | — | 88.3% | -$117.7M | $20.70B |
| FY 2023 | $0 | $371.62B | — | 89.6% | -$154.2M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KOD // BETA 0.90
UNH // BETA 0.33